Besma Benredjem, Besma Benredjem, Graciela Pineyro, & Graciela Pineyro. (2023). A type II cannabis extract and a 1: 1 blend of Δ(9)-tetrahydrocannabinol and cannabidiol display distinct antinociceptive profiles and engage different endocannabinoid targets when administered into the subarachnoid space. Frontiers Media S.A..
Chicago Style (17th ed.) CitationBesma Benredjem, Besma Benredjem, Graciela Pineyro, and Graciela Pineyro. A Type II Cannabis Extract and a 1: 1 Blend of Δ(9)-tetrahydrocannabinol and Cannabidiol Display Distinct Antinociceptive Profiles and Engage Different Endocannabinoid Targets When Administered into the Subarachnoid Space. Frontiers Media S.A., 2023.
MLA (9th ed.) CitationBesma Benredjem, et al. A Type II Cannabis Extract and a 1: 1 Blend of Δ(9)-tetrahydrocannabinol and Cannabidiol Display Distinct Antinociceptive Profiles and Engage Different Endocannabinoid Targets When Administered into the Subarachnoid Space. Frontiers Media S.A., 2023.